logo
  • 首页
  • 学术期刊
  • 论文检测
  • AIGC检测
  • 热点
  • 更多
    • 数据

US labelling update for 'Zetia'

被引:0
|
作者:
机构:
来源:
Reactions Weekly | 2003年 / 959卷 / 1期
关键词:
Public Health; Clinical Trial; Adverse Reaction; Myopathy; Safety Profile;
D O I:
10.2165/00128415-200309590-00003
中图分类号:
学科分类号:
摘要:
引用
收藏
页码:2 / 2
相关论文
共 50 条
  • [1] US FDA issues reminder to update NSAID labelling
    Reactions Weekly, 2005, 1057 (1) : 3 - 3
  • [2] US NovoSeven labelling update includes new AEs and warnings
    Reactions Weekly, 2005, 1081 (1) : 4 - 4
  • [3] No changes to Tysabri labelling, risk management plan - US FDA update
    Reactions Weekly, 2009, 1271 (1) : 2 - 2
  • [4] US FOOD LABELLING
    不详
    论文数: 0 引用数: 0 h-index: 0
    不详
    FOOD AUSTRALIA, 2014, 66 (02): : 10 - 10
  • [5] Labelling changes in the US
    Reactions Weekly, 2002, 897 (1) : 2 - 2
  • [6] Infliximab: labelling update in Malaysia
    Reactions Weekly, 2017, 1634 (1) : 6 - 6
  • [7] US Mifeprex labelling revised
    Reactions Weekly, 2004, 1028 (1) : 2 - 2
  • [8] US Novantrone labelling revised
    Reactions Weekly, 2005, 1053 (1) : 2 - 2
  • [9] US labelling change for `Permax'
    Reactions Weekly, 2003, 940 (1) : 2 - 2
  • [10] Zafirlukast labelling revised in the US
    Reactions Weekly, 2000, 820 (1) : 3 - 3
← 12345 →